Hinge Health, Inc.

NYSE:HNGE

Medical - Healthcare Information Services

Healthcare
$114.53 -0.36%

-$0.24 today

Market cap
$9.31B
Beta
1.99
P/E (TTM)
-10.3
EPS (TTM)
-$6.49
52W Low $30.08High $70.72

Volume 1.23M

Average 1.34M

HNGE Common Stock Repurchased

Cash spent buying back the company's own shares.

Hinge Health, Inc.NYSE: HNGE

Common Stock Repurchased · Q2 FY2026 · quarter ended Jun 2026

Common stock repurchased turns negative

Q2 FY2026 common stock repurchased was -$26.53M, compared with $0 a year earlier. Trailing-twelve-month common stock repurchased was -$196.52M.

Context

  • Common stock repurchased amounted to 11.1% of revenue in FY2025, up 11.1 pp from a year earlier.
  • Common stock repurchased increased in 0 of the last 2 fiscal years.
  • FY2025 was the lowest annual figure in the 3 fiscal years shown.

What to watch

Whether quarterly common stock repurchased holds near -$26.53M or moves back toward the trailing-twelve-month quarterly average of -$49.13M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
-$26.53M-74.7% QoQ
Last fiscal yearDec 2025
-$65.03M— YoY
LTMJun 2026
-$196.52M— YoY
Common Stock Repurchased past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Common Stock Repurchased history

USD · from the cash flow

Latest · FY2025
(65.03M) USD
Year-over-year change
—

Common Stock Repurchased vs competitors

How HNGE compares with its peers on the latest reported figures

  • HNGE's LTM Jun 2026 common stock repurchased of $196.52M is the 2nd largest of the 5 companies compared; the peer median is $2.78M.
  • Common stock repurchased amounts to 27.3% of revenue for HNGE, versus a peer median of 0.4%.
HNGE Competitors Peer median
Common Stock Repurchased for HNGE and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SNNSmith & Nephew plcFY2025$502M —+47.0%8.1%
HNGEHinge Health, Inc.LTM Jun 2026$196.52M ——27.3%
USPHU.S. Physical Therapy, Inc.LTM Mar 2026$5.57M ——0.8%
ENOVEnovis CorporationLTM Apr 2026$0 ——0.0%
OMDAOmada HealthLTM Mar 2026$0 ——0.0%
Peer median (excluding HNGE) $2.78M—+47.0%0.4%

Competitors are the stored peer set for HNGE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(108.14M)(11.93M)(528.26M)
Depreciation & Amortization5.63M5.95M5.13M
Deferred Income Tax(473K)(585K)53K
Stock-Based Compensation1.65M739K643.01M
Change in Working Capital9.41M13.5M(2.01M)
Accounts Receivables(23.13M)(1.34M)(26.63M)
Inventory10.57M608K(4.76M)
Accounts Payables0(10.98M)29.41M
Other Working Capital21.97M25.21M(31K)
Other Non-Cash Items28.02M41.33M53.52M
Operating Cash Flow(63.91M)49M171.44M
Capital Expenditures(4.62M)(3.77M)(708K)
Acquisitions (Net)00(4M)
Purchases of Investments(453.34M)(324.54M)(472.29M)
Sales of Investments459.45M346.63M368.59M
Other Investing Activities(2.64M)(2.73M)(5.36M)
Investing Cash Flow1.5M18.31M(113.76M)
Debt Repayment000
Common Stock Issued0610K265.2M
Common Stock Repurchased00(65.03M)
Dividends Paid000
Other Financing Activities(3M)(2.81M)(350.64M)
Financing Cash Flow(3M)(2.2M)(150.47M)
Effect of Forex Changes000
Net Change in Cash(65.41M)65.11M(92.79M)
Free Cash Flow(68.52M)45.23M170.73M

Hinge Health, Inc.

NYSE:HNGE

Intrinsic Alpha fair value

Locked

Current Price

$114.53

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.